Summary
The human pregnane X receptor (hPXR) plays a critical role in the metabolism, transport and clearance of xenobiotics in the liver and intestine. The hPXR can be activated by a structurally diverse of drugs to initiate clinically relevant drug-drug interactions. In this article, in silico investigation was performed on a structurally diverse set of drugs to identify critical structural features greatly related to their agonist activity towards hPXR. Heuristic method (HM)-Best Subset Modeling (BSM) and HM-Polynomial Neural Networks (PNN) were utilized to develop the linear and non-linear quantitative structure-activity relationship models. The applicability domain (AD) of the models was assessed by Williams plot. Statistically reliable models with good predictive power and explain were achieved (for HM-BSM, r 2=0.881, q 2LOO =0.797, q 2EXT =0.674; for HM-PNN, r 2=0.882, q 2LOO =0.856, q 2EXT =0.655). The developed models indicated that molecular aromatic and electric property, molecular weight and complexity may govern agonist activity of a structurally diverse set of drugs to hPXR.
Similar content being viewed by others
References
Dussault I, Forman BM. The nuclear receptor PXR: a master regulator of “homeland” defense. Crit Rev Eukaryot Gene Expr, 2012, 12(1): 53–64
Staudinger J, Liu Y, Madan A, et al. Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. Drug Metab Dispos, 2001, 29(11): 1467–1472
Goodwin B, Hodgson E, Liddle C. The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol Pharmacol, 1999, 56(6): 1329–1339
Blumberg B, Sabbagh WJ, Juguilon H, et al. SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev, 1998, 12(10): 3195–3205
Goodwin B, Moore LB, Stoltz CM, et al. Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor. Mol Pharmacol, 2001, 60(3): 427–431
Guengerich FP. Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol, 1999, 39: 1–17
Watkins RE, Wisely GB, Moore LB, et al. The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science, 2001, 292(5525): 2329–2333
Watkins RE, Noble SM, Redinbo MR. Structural insights into the promiscuity and function of the human pregnane X receptor. Curr Opin Drug Discov Dev, 2002, 5(1): 150–158
Fuhr U. Induction of drug metabolising enzymes: pharmacokinetic and toxicological consequences in humans. Clin Pharmacokinet, 2000, 38(6): 493–504
Teotico DG, Bischof JJ, Peng L, et al. Structural basis of human pregnane X receptor activation by the hops constituent colupulone. Mol Pharmacol, 2008, 74(6): 1512–1520
Zhang YM, Yang XS, Sun C, et al. Quantitative structure-activity relationship of compounds binding to estrogen receptor β based on heuristic method. Sci China Ser B, 2011, 54(1): 237–243
Ekins S, Kortagere S, Iyer M, et al. Challenges predicting ligand-receptor interactions of promiscuous proteins: the nuclear receptor PXR. PLoS Comput Biol, 2009, 5(12): 1–12
Wang Y, Liu H, Zhao C, et al. Quantitative structure-activity relationship models for prediction of the toxicity of polybrominated diphenyl ether congeners. Environ Sci Technol, 2005, 39(13): 4961–4966
Liu H, Papa E, Gramatica P. QSAR prediction of estrogen activity for a large set of diverse chemicals under the guidance of OECD principles. Chem Res Toxicol, 2006, 19(11): 1540–1548
Li F, Xie Q, Li X, et al. Hormone activity of hydroxylated polybrominated diphenyl ethers to human thyroid receptors α: in vitro and in silico investigations. Environ Health Perspect, 2010, 118(5): 602–606
Zhang YM, Yang XS, Sun C, et al. QSAR prediction of antagonistic activity of PCBs towards human PXR by using heuristic method and best subset modeling. Sci China Ser B, 2012, 55(7): 1459–1466
Rao HB, Wang YY, Zeng XY, et al. In silico identification of human pregnane X receptor activators from molecular descriptors by machine learning approaches. Chemomet Intell Lab Syst, 2012, 118: 271–279
Chen S, He N, Chen W, et al. Molecular insights into the promiscuous interaction of human pregnane X receptor (hPXR) with diverse environmental chemicals and drug compounds. Chemosphere, 2014, 96: 138–145
Xiao L, Nickbarg E, Wang W, et al. Evaluation of in vitro PXR-based assays and in silico modeling approaches for understanding the binding of a structurally diverse set of drugs to PXR. Biochem Pharmacol, 2011, 81(5): 669–679
Ekins S, Chang C, Mani S, et al. Human pregnane X receptor antagonists and agonists define molecular requirements for different binding sites. Mol Pharmacol, 2007, 72(3): 592–603
Sybyl Version 7.3, Tripos Associates, St. Louis (MO), 2006.
Tetko IV, Aksenova TI, Volkovich VV, et al. Polynomial neural network for linear and non-linear model selection in quantitative-structure activity relationship studies on the internet. SAR QSAR Environ Res, 2000, 11(3-4): 263–280
Todeschini R, Consonni V. Handbook of molecular descriptors, Wiley-VCH, Weinheim, 2000.
de Melo EB. Multivariate SAR/QSAR of 3-aryl-4-hydroxyquinolin-2(1H)-one derivatives as type I fatty acid synthase (FAS) inhibitors. Eur J Med Chem, 2010, 45(12): 5817–5826
Ngan CH, Beglov D, Rudnitskaya AN, et al. The structural basis of pregnane X receptor binding promiscuity. Biochemistry, 2009, 48(48): 11572–11581
Balaban AT, Ciubotariu D, Medeleanu MJ. Topological indices and real number vertex invariants based on graph eigenvalues or eigenvectors. Chem Inf Comput Sci, 1991, 31: 517–523
Matter H, Anger LT, Giegerich C, et al. Development of in silico filters to predict activation of the pregnane X receptor (PXR) by structurally diverse drug-like molecules. Bioorg Med Chem, 2012, 20(18): 5352–5365
Author information
Authors and Affiliations
Corresponding authors
Additional information
The project was supported by grants from the Natural Science Research Project of Institution of Higher Education of Jiangsu Province (No. 11KJB180006) and National Natural Science Foundation of China (No. 21277074 and No. 81302458).
Rights and permissions
About this article
Cite this article
Zhang, Ym., Chang, Mj., Yang, Xs. et al. In silico investigation of agonist activity of a structurally diverse set of drugs to hPXR using HM-BSM and HM-PNN. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 36, 463–468 (2016). https://doi.org/10.1007/s11596-016-1609-4
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-016-1609-4